Patient Guide: A Study of TAK-341 in Treatment of Multiple System Atrophy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 41 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05526391
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple System Atrophy, Shy-Drager Syndrome, Atrophy
Phase: PHASE2

Where You Can Participate

This study is available at 41 locations across the country.

Top locations include:
  • • Farmington Hills, Michigan
  • • Rochester, Minnesota
  • • New York, New York
  • • And 38 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of TAK-341 in Treatment of Multiple System Atrophy - Join Clinical Trial NCTNCT05526391

How to Join This Clinical Trial - NCTNCT05526391

Learn how to participate in this PHASE2 trial studying an investigational therapy for Multiple System Atrophy, Shy-Drager Syndrome, Atrophy. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple System Atrophy, Shy-Drager Syndrome, Atrophy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple System Atrophy, Shy-Drager Syndrome, Atrophy
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05526391 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 41 locations. Find a study site near you:

Clinical Research Site

Farmington Hills, Michigan 48025 - United States

Status: Contact for availability

Clinical Research Site

Rochester, Minnesota 55905-0001 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10016-6402 - United States

Status: Contact for availability

Clinical Research Site

Durham, North Carolina 27705-4410 - United States

Status: Contact for availability

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: Contact for availability

Clinical Research Site

Dallas, Texas 75390-7208 - United States

Status: Contact for availability

Clinical Research Site

Spokane, Washington 99202-1342 - United States

Status: Contact for availability

Clinical Research Site

Graz, Steiermark 8036 - Austria

Status: Contact for availability

Clinical Research Site

Kobenhavn NV, Capital 2400 - Denmark

Status: Contact for availability

Clinical Research Site

Aarhus N, 8200 - Denmark

Status: Contact for availability

And 31 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Multiple System Atrophy, Shy-Drager Syndrome, Atrophy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships